Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
TopWeightLoss.ioTreatmentsHub

wellmedr vs embody vs trimrx: Price, Freedom, Flexibility

Last updated: Aug 16, 2026

We may earn a commission when you visit providers through links on this page - it never affects our rankings (how we stay objective). This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

Here’s the short version

This trio spans the market's price range - $59 to $179 for the same compounded semaglutide - which makes it a clean test of what the extra money buys. The answer: commitment structure. wellmedr trades a 12-month plan for the lowest price, embody charges $10 more for total freedom, and trimrx charges a premium for a no-contract model with optional multi-month discounts and closer clinical guidance.

wellmedr logo
1,205 reviews onTrustpilot

Long-Term Weight Management Support

Visit wellmedr
embody logo
4,956 reviews onTrustpilot

Limited Offer - GLP-1 for $69/mon

Visit embody
trimrx logo
5,497 reviews onTrustpilot

Limited time offer - $140 off all weight loss plans

Visit trimrx

wellmedr vs embody vs trimrx: side by side

Real published prices and terms - the differences that actually decide this matchup.

wellmedrembodytrimrx
Semaglutide$59/mo (12-month plan), same price at every dose$69/mo, flat at every dose$179/mo (reg. $299)
Tirzepatide$99/mo$119/mo$259/mo
Billing & commitmentMonthly billing - best rate locks on a 12-month planMonthly - no commitment, cancel anytimeMonthly - no long-term contract; multi-month discounts
ShippingFree, every 4 weeks, discreet packagingFree 1-2 day, tracked & insuredFree home delivery
SupportMedical Weight-Care Coach on every planLicensed doctors, medical director & nursing teamLicensed clinical guidance through dose changes
Guarantee / refundWeight-loss warranty (terms on site)Full refund if you're not approved-
Standout1M+ patients; board-certified specialistsLegitScript-certified; 503A pharmaciesFlexibility-first: month-to-month always available

Our verdict

For most budget-driven shoppers this comes down to wellmedr vs embody: $59 with a year's commitment, or $69 with none - both legitimate, both dose-flat. trimrx earns its $179 only if its specific mix matters to you: month-to-month freedom plus ongoing clinical support through dose changes, without the budget tier's leaner service. If you can't articulate why you'd pay the difference, don't.

wellmedr vs embody vs trimrx: FAQs

Why does trimrx cost more than wellmedr and embody?

trimrx prices at $179/month (regularly $299) with no long-term contract, multi-month discounts, and clinical support included through treatment. wellmedr ($59 on a 12-month plan) and embody ($69 flat) run leaner support models at lower prices. All three prescribe the same compounded semaglutide after a licensed-provider review.

Which is best if I don't want any commitment?

embody - its $69/month is flat with no commitment, and it refunds you in full if a provider doesn't approve treatment. trimrx is also month-to-month with no contract, at $179. wellmedr's best rate ($59) locks on a 12-month plan.

Do any of the three offer a guarantee?

wellmedr backs treatment with a weight-loss warranty (terms on its site), and embody offers a full refund if you're not approved. trimrx doesn't advertise a comparable guarantee.

Break it down two at a time

The head-to-head comparisons between these providers.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)